Hims Weight Loss Review 2026

Hims Weight Loss Review 2026: Pricing, How It Works, and Who It's Best For

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.

Hims & Hers (NYSE: HIMS) is one of the largest telehealth companies in the US, serving millions of customers across sexual health, dermatology, mental health, and weight loss. Following a March 9, 2026 settlement with Novo Nordisk, Hims exited compounding and now operates as an authorized distributor of brand-name GLP-1 medications — injectable Wegovy, oral Wegovy, and Ozempic — with cash-pay pricing starting at $149/month.

As a publicly traded company, Hims carries audited financials and SEC oversight that smaller telehealth startups don't. Whether that translates to a better weight loss experience depends on what you need from a provider.

How does Hims' weight loss program work?

Hims uses an async-only model — no video or phone consultations. Most patients get a prescription decision within 24 hours, and medication ships free in 3–5 business days.

1. Online intake — Complete a medical questionnaire covering health history, current medications, BMI, and weight goals. The intake screens for contraindications (e.g., personal or family history of medullary thyroid carcinoma, MEN 2 syndrome).
2. Provider evaluation — A board-certified physician or licensed provider reviews your submission asynchronously. Most patients hear back within 24 hours.
3. Medication shipped — If approved, medication ships free, arriving in 3–5 business days.
4. Ongoing support — Unlimited provider messaging for dose adjustments, side effect questions, and follow-up.

How much does Hims weight loss cost per month?

Following the March 9, 2026 Novo Nordisk settlement, Hims exited compounding. Branded GLP-1 medications are now available at Novo Nordisk's adjusted self-pay prices: oral Wegovy starts at $149/month, injectable Wegovy at $299/month, Zepbound (tirzepatide) at $399/month.

Pricing last verified April 2026. We update pricing data monthly. Contact us if you spot an error.

Medication	Monthly Cost	Notes
Oral Wegovy (semaglutide pill)	$149/mo	Cash-pay; FDA-approved oral GLP-1
Injectable Wegovy (semaglutide)	$299/mo	Cash-pay; FDA-approved weekly injection
Ozempic (semaglutide)	$149/mo	Cash-pay; FDA-approved for type 2 diabetes, prescribed off-label for weight loss
Brand Zepbound (tirzepatide)	$399/mo	Cash-pay; FDA-approved for chronic weight management

Pricing aligns with other telehealth platforms operating under Novo Nordisk's adjusted self-pay structure. Compounded semaglutide is no longer available from Hims.

What medications does Hims offer for weight loss?

As of March 9, 2026, Hims exclusively offers FDA-approved branded medications following its settlement with Novo Nordisk:

• Oral Wegovy (semaglutide pill) — FDA-approved oral GLP-1 receptor agonist for weight management ($149/mo cash-pay). Hims is an authorized Novo Nordisk distributor.
• Injectable Wegovy (semaglutide) — FDA-approved weekly subcutaneous injection for weight management ($299/mo cash-pay).
• Ozempic (semaglutide) — FDA-approved for type 2 diabetes; often prescribed off-label for weight loss ($149/mo cash-pay).
• Brand Zepbound (tirzepatide) — Dual GIP/GLP-1 agonist; FDA-approved for chronic weight management ($399/mo cash-pay).

Compounded semaglutide, including the previously offered oral compounded tablets, is no longer available from Hims.

Clinical Protocol

Hims operates as a brand-only, async-only platform — no compounded medications, no video consultations, no tirzepatide as of early 2026.

What doses does Hims start patients on?

Titration schedules vary by formulation:

• Oral Wegovy 4 mg tier: 3 mg/day × 4 weeks → 7 mg/day × 4 weeks → 14 mg/day maintenance
• Oral Wegovy 9–25 mg tier: 3 mg/day × 4 weeks → 7 mg/day × 4 weeks → 14 mg/day × 4 weeks → 25 mg/day maintenance
• Wegovy injectable (semaglutide): 0.25 mg/week × 4 weeks → 0.5 mg/week × 4 weeks → 1.0 mg/week × 4 weeks → 1.7 mg/week × 4 weeks → 2.4 mg/week maintenance
• Wegovy HD (7.2 mg): Higher-dose option for patients who plateau at 2.4 mg. Available only after completing full standard titration. Insurance-dependent.

What medications does Hims currently prescribe?

• Brand oral Wegovy (4 mg, ~$149/mo; 9–25 mg, ~$299/mo cash-pay) — FDA-approved
• Brand Wegovy injectable — FDA-approved; cash-pay or insurance
• Brand Ozempic (semaglutide; primarily indicated for type 2 diabetes, prescribed off-label for weight management) — FDA-approved
• Wegovy HD (semaglutide 7.2 mg) — FDA-approved April 2026; insurance-dependent
• No tirzepatide — Hims dropped Zepbound from their formulary in early 2026. Patients who need tirzepatide access should evaluate Ro, Calibrate, or Found.
• No compounded medications — Hims exited compounding following a March 9, 2026 settlement with Novo Nordisk

Does Hims require lab work before prescribing?

No. Hims does not include or require any lab testing. Patients escalating to Wegovy HD or on long-term semaglutide should discuss periodic monitoring of thyroid function, GI markers, and metabolic panels with their primary care provider. Hims does not provide this monitoring.

Who prescribes at Hims, and how does the consultation work?

Hims' prescribers are board-certified physicians (MD/DO) or licensed providers (NP/PA). Hims does not specify prescriber seniority for individual patient cases. The consultation model is async-only: providers review intake forms and respond via secure messaging, typically within 24 hours. No video consultations are offered.

How often does Hims check in with patients?

No scheduled follow-up cadence. Hims offers unlimited provider messaging for dose questions and adjustments, but all contact is patient-initiated. Dose escalation decisions are made through the message thread, not structured visits.

How does Hims manage side effects?

Provider messaging is available for side effect questions. No structured antiemetic protocol is documented. Standard guidance: remain at your current dose until tolerating well before escalating. No dietary coaching, behavioral support, or nutritional guidance is included.

How effective is Hims weight loss treatment?

The clinical evidence for semaglutide and tirzepatide is well-established:

• Semaglutide (STEP 1): 14.9% mean body weight loss over 68 weeks with 2.4mg weekly semaglutide vs 2.4% with placebo (Wilding et al., NEJM 2021).
• Tirzepatide (SURMOUNT-1): 22.5% mean body weight loss at the highest dose (15mg) over 72 weeks vs 2.4% with placebo (Jastreboff et al., NEJM 2022).

Individual results vary. These trials were conducted with brand-name medications — the same products Hims now exclusively dispenses.

What are the pros of Hims weight loss?

• Publicly traded company — Financial statements are audited and public; subject to SEC oversight. This provides accountability that private startups lack.
• Massive scale — Hims serves millions of patients, suggesting operational maturity and supply chain reliability.
• FDA-approved medications only — All offerings are brand-name, FDA-approved products. No compounded medication risk.
• Oral Wegovy option — The FDA-approved semaglutide pill at $149/mo is a practical alternative for patients who prefer oral dosing over injections.
• Authorized Novo Nordisk distributor — Direct partnership ensures supply chain reliability and authentic branded product.
• Competitive cash-pay pricing — Oral Wegovy and Ozempic at $149/mo are in line with Novo Nordisk's adjusted self-pay structure across all platforms.

What are the cons of Hims weight loss?

• Injectable Wegovy at $299/mo is expensive — Patients who previously paid $199/mo for compounded semaglutide will now pay more for the injectable brand option. The oral Wegovy at $149/mo partially offsets this, but injectable users face a price increase.
• No video consultations — Async-only care model.
• No lab testing — Metabolic blood work is not included or required.
• Limited to GLP-1 medications — No broader peptide or weight management drug options.
• Compounded option gone — Patients who relied on Hims' $199/mo compounded semaglutide must either switch to brand (at $149–$299/mo) or find another provider.

Who is Hims best for?

• Patients who want FDA-approved branded GLP-1 medications with reliable supply from an authorized distributor
• People who prefer oral semaglutide — Hims is one of the few telehealth platforms offering FDA-approved oral Wegovy at $149/mo
• Existing Hims customers who already use the platform for other health services
• Patients comfortable with async digital care who want public company accountability

Who should look elsewhere?

• Patients seeking the lowest possible price for injectables — Injectable Wegovy at $299/mo is the higher end of the branded market. Check if your insurer covers Wegovy before paying cash-pay.
• Patients wanting comprehensive coaching — Found and Calibrate offer more holistic programs
• Those needing video consultations or lab testing — Calibrate is a better fit
• Patients who previously used Hims for compounded semaglutide — The $199/mo option is gone; evaluate the oral Wegovy ($149/mo) or injectable ($299/mo) against other platforms

Is Hims weight loss worth it?

For branded GLP-1 weight loss, Hims is a legitimate option: publicly traded, audited financials, authorized Novo Nordisk distributor, FDA-approved medications only. The oral Wegovy at $149/mo stands out — few telehealth platforms offer it. Injectable Wegovy at $299/mo is worth comparing against other platforms or checking insurer coverage before paying cash. Hims works best for patients already in its ecosystem, those who prefer oral semaglutide, or those who want public company accountability.

Rating: 3.8/5

Frequently Asked Questions

Is Hims weight loss legit? Yes. Hims & Hers (NYSE: HIMS) is a publicly traded telehealth company with audited financials and SEC oversight. Their GLP-1 weight loss program uses licensed physicians and exclusively provides FDA-approved branded medications through an authorized Novo Nordisk distribution agreement. The async-only model is a real limitation, but the platform is legitimate.

How much does Hims weight loss cost without insurance? As of April 2026, Hims offers oral Wegovy (semaglutide pill) starting at $149/month and injectable Wegovy at $299/month cash-pay. Ozempic is also available at $149/month. Zepbound is $399/month cash-pay. Compounded semaglutide is no longer available.

Does Hims take insurance for weight loss? Hims assists with prior authorization for brand Wegovy through insurance. The cash-pay medication prices ($149–$299/month) are available without insurance. Hims no longer offers compounded semaglutide as of March 9, 2026.

How do I cancel Hims weight loss? You can cancel your Hims weight loss subscription through your account settings online or by contacting Hims support. The subscription is month-to-month with no long-term commitment required.

Is Hims' semaglutide FDA-approved? Yes. As of April 2026, Hims exclusively offers FDA-approved branded semaglutide: oral Wegovy (pill), injectable Wegovy, and Ozempic. All are manufactured by Novo Nordisk. Hims became an authorized distributor following the March 9, 2026 settlement that ended compounding.

How does Hims compare to Ro for weight loss? Both platforms now offer branded-only GLP-1 medications under Novo Nordisk's self-pay pricing. Hims' oral Wegovy starts at $149/mo — comparable pricing to Ro's brand offerings under the same structure. Hims stands out for its oral Wegovy access and public company accountability. Neither platform offers compounded semaglutide as of April 2026.

Data Sources & Methodology

Pricing and protocol data sourced from Hims & Hers's public website and newsroom, and corroborated via third-party reporting on the March 9, 2026 Novo Nordisk settlement. Verified March 31, 2026. Patient experience data drawn from public reviews (Google, Trustpilot, Reddit) and independent patient outreach. Telehealth Ally has no commercial relationship with this provider. Rankings and ratings are editorial-only.

Related Resources

• Hims Provider Profile — Medications, pricing, and consultation details
• Hims vs Ro: Head-to-Head Comparison — Which budget platform wins?
• Henry Meds vs Hims — Comparing two popular GLP-1 providers
• Best GLP-1 Weight Loss Programs 2026 — All major providers ranked
• GLP-1 Cost & Insurance FAQ — What you'll actually pay
• Hers vs Hims Weight Loss — Are they actually different?
• Mochi Health vs Hims — Specialist vs mass-market approach